Cellectar Biosciences ROE 2006-2019 | CLRB

Current and historical return on equity (ROE) values for Cellectar Biosciences (CLRB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Cellectar Biosciences ROE for the three months ending March 31, 2019 was -169.87%.
Cellectar Biosciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $-0.02B $0.01B -142.22%
2018-12-31 $-0.02B $0.01B -142.86%
2018-09-30 $-0.02B $0.02B -170.00%
2018-06-30 $-0.02B $0.01B -193.55%
2018-03-31 $-0.02B $0.01B -162.16%
2017-12-31 $-0.02B $0.01B -136.36%
2017-09-30 $-0.02B $0.01B -127.66%
2017-06-30 $-0.01B $0.01B -119.15%
2017-03-31 $-0.01B $0.01B -113.04%
2016-12-31 $-0.01B $0.01B -102.86%
2016-09-30 $-0.00B $0.01B -34.78%
2016-06-30 $-0.00B $0.01B -50.00%
2016-03-31 $-0.00B $0.00B -100.00%
2015-12-31 $-0.01B $0.00B -200.00%
2015-09-30 $-0.01B $0.00B -240.00%
2015-06-30 $-0.01B $0.00B -103.70%
2015-03-31 $-0.01B $0.01B -127.27%
2014-12-31 $-0.01B $0.01B -200.00%
2014-09-30 $-0.01B $0.01B -327.27%
2014-06-30 $-0.01B $-0.00B -2000.00%
2014-03-31 $-0.01B $-0.00B -400.00%
2013-12-31 $-0.01B $0.00B -222.22%
2013-09-30 $-0.01B $0.00B -123.08%
2013-06-30 $-0.01B $0.01B -129.03%
2013-03-31 $-0.01B $0.01B -108.11%
2012-12-31 $-0.01B $0.01B -94.74%
2012-09-30 $-0.01B $0.01B -97.30%
2012-06-30 $-0.01B $0.01B -94.12%
2012-03-31 $-0.01B $0.01B -120.00%
2011-12-31 $-0.01B $0.01B -145.45%
2011-09-30 $-0.01B $0.01B -184.62%
2011-06-30 $-0.01B $0.01B -500.00%
2011-03-31 $-0.00B $0.00B 320.00%
2010-12-31 $0.00B $0.00B -160.00%
2010-09-30 $-0.01B $-0.00B 338.46%
2010-06-30 $-0.01B $-0.00B 433.33%
2010-03-31 $-0.02B $0.00B 457.14%
2009-12-31 $-0.02B $-0.01B 766.67%
2009-09-30 $-0.01B $-0.00B 480.00%
2009-06-30 $-0.01B $-0.00B 436.36%
2009-03-31 $-0.01B $0.00B 480.00%
2008-12-31 $-0.02B $-0.01B 453.33%
2008-09-30 $-0.02B $-0.00B 1760.00%
2008-06-30 $-0.03B $-0.00B -1111.11%
2008-03-31 $-0.02B $-0.00B -320.00%
2007-12-31 $-0.02B $0.00B -185.37%
2007-09-30 $-0.02B $0.01B -125.00%
2007-06-30 $-0.01B $0.02B -96.00%
2007-03-31 $-0.01B $0.01B -75.00%
2006-12-31 $-0.01B $0.01B -56.14%
2006-09-30 $-0.01B $0.01B -47.06%
2006-06-30 $-0.00B $0.02B -37.21%
2006-03-31 $-0.00B $0.02B -57.14%
2005-12-31 $-0.00B $0.01B -109.09%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.020B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33